Literature DB >> 27567291

Postmortem structural studies of the thalamus in schizophrenia.

Karl-Anton Dorph-Petersen1, David A Lewis2.   

Abstract

In this review, we seek to answer the following question: Do findings in the current literature support the idea that thalamo-cortical dysfunction in schizophrenia is due to structural abnormalities in the thalamus? We base our review on the existing literature of design-unbiased stereological studies of the postmortem thalamus from subjects with schizophrenia. Thus, all reported results are based upon the use of unbiased principles of sampling to determine volume and/or total cell numbers of thalamus or its constituent nuclei. We found 28 such papers covering 26 studies. In a series of tables we list all positive and negative findings from the total thalamus, the mediodorsal, pulvinar and anterior nuclei, as well as less frequently studied thalamic regions. Only four studies examined the entire thalamus and the results were inconsistent. We found largely consistent evidence for structural changes (reduced volume and cell numbers) in the pulvinar located in the posterior thalamus. In contrast, findings in the mediodorsal thalamic nucleus are inconsistent, with the largest and most recent studies generally failing to support earlier reports of a lower number of neurons in schizophrenia. Thus, the current findings of stereological studies of the thalamus in schizophrenia support the idea that thalamo-cortical dysfunction in schizophrenia might be attributable, at least in part, to structural alterations in the pulvinar that could impair thalamic inputs to higher order cortical association areas in the frontal and parietal lobes. However, more studies are needed before robust conclusions can be drawn.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell number; Postmortem; Schizophrenia; Stereology; Thalamus

Mesh:

Year:  2016        PMID: 27567291      PMCID: PMC5746188          DOI: 10.1016/j.schres.2016.08.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  42 in total

1.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.

Authors:  G J Popken; W E Bunney; S G Potkin; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study.

Authors:  Peter Danos; Bruno Baumann; Hans Gert Bernstein; Renate Stauch; Dieter Krell; Peter Falkai; Bernhard Bogerts
Journal:  Psychiatry Res       Date:  2002-02-15       Impact factor: 3.222

3.  Neuronal deficit in medial pulvinar from right but not left hemisphere in schizophrenia.

Authors:  Maxwell I Mileaf; William Byne
Journal:  Schizophr Res       Date:  2011-11-12       Impact factor: 4.939

4.  Reduction of right medial pulvinar volume and neuron number in schizophrenia.

Authors:  William Byne; Jason Fernandes; Vhram Haroutunian; Dennis Huacon; Smith Kidkardnee; John Kim; Alex Tatusov; Uma Thakur; Georgia Yiannoulos
Journal:  Schizophr Res       Date:  2006-12-01       Impact factor: 4.939

5.  Regionally specific loss of neurons in the aging human hippocampus.

Authors:  M J West
Journal:  Neurobiol Aging       Date:  1993 Jul-Aug       Impact factor: 4.673

6.  The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.

Authors:  B Pakkenberg
Journal:  Schizophr Res       Date:  1992-07       Impact factor: 4.939

7.  Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus.

Authors:  B Pakkenberg
Journal:  Neuropathol Appl Neurobiol       Date:  1993-10       Impact factor: 8.090

8.  New stereological method for obtaining unbiased and efficient estimates of total nerve cell number in human brain areas. Exemplified by the mediodorsal thalamic nucleus in schizophrenics.

Authors:  B Pakkenberg; H J Gundersen
Journal:  APMIS       Date:  1989-08       Impact factor: 3.205

9.  No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients.

Authors:  L Korbo; I Amrein; H-P Lipp; D Wolfer; L Regeur; S Oster; B Pakkenberg
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

10.  Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.

Authors:  T G M van Erp; D P Hibar; J M Rasmussen; D C Glahn; G D Pearlson; O A Andreassen; I Agartz; L T Westlye; U K Haukvik; A M Dale; I Melle; C B Hartberg; O Gruber; B Kraemer; D Zilles; G Donohoe; S Kelly; C McDonald; D W Morris; D M Cannon; A Corvin; M W J Machielsen; L Koenders; L de Haan; D J Veltman; T D Satterthwaite; D H Wolf; R C Gur; R E Gur; S G Potkin; D H Mathalon; B A Mueller; A Preda; F Macciardi; S Ehrlich; E Walton; J Hass; V D Calhoun; H J Bockholt; S R Sponheim; J M Shoemaker; N E M van Haren; H E H Pol; R A Ophoff; R S Kahn; R Roiz-Santiañez; B Crespo-Facorro; L Wang; K I Alpert; E G Jönsson; R Dimitrova; C Bois; H C Whalley; A M McIntosh; S M Lawrie; R Hashimoto; P M Thompson; J A Turner
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

View more
  22 in total

1.  MAPBOT: Meta-analytic parcellation based on text, and its application to the human thalamus.

Authors:  Rui Yuan; Paul A Taylor; Tara L Alvarez; Durga Misra; Bharat B Biswal
Journal:  Neuroimage       Date:  2017-06-17       Impact factor: 6.556

2.  A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder.

Authors:  Paulo Lizano; Deepthi Bannai; Olivia Lutz; Leo A Kim; John Miller; Matcheri Keshavan
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 3.  The influence of subcortical shortcuts on disordered sensory and cognitive processing.

Authors:  Jessica McFadyen; Raymond J Dolan; Marta I Garrido
Journal:  Nat Rev Neurosci       Date:  2020-04-08       Impact factor: 34.870

Review 4.  Myths and truths about the cellular composition of the human brain: A review of influential concepts.

Authors:  Christopher S von Bartheld
Journal:  J Chem Neuroanat       Date:  2017-09-02       Impact factor: 3.052

5.  Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.

Authors:  Anna S Huang; Baxter P Rogers; Julia M Sheffield; Maria E Jalbrzikowski; Alan Anticevic; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Am J Psychiatry       Date:  2020-09-11       Impact factor: 18.112

6.  Differential Roles of Mediodorsal Nucleus of the Thalamus and Prefrontal Cortex in Decision-Making and State Representation in a Cognitive Control Task Measuring Deficits in Schizophrenia.

Authors:  Adele L DeNicola; Min-Yoon Park; David A Crowe; Angus W MacDonald; Matthew V Chafee
Journal:  J Neurosci       Date:  2020-01-15       Impact factor: 6.167

7.  Thalamic, Amygdalar, and hippocampal nuclei morphology and their trajectories in first episode psychosis: A preliminary longitudinal study.

Authors:  Dung Hoang; Paulo Lizano; Olivia Lutz; Victor Zeng; Nicolas Raymond; Jean Miewald; Deborah Montrose; Matcheri Keshavan
Journal:  Psychiatry Res Neuroimaging       Date:  2021-01-08       Impact factor: 2.376

Review 8.  Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia.

Authors:  Jason Smucny; Samuel J Dienel; David A Lewis; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2021-07-20       Impact factor: 7.853

9.  Metabolite Alterations in Adults With Schizophrenia, First Degree Relatives, and Healthy Controls: A Multi-Region 7T MRS Study.

Authors:  S Andrea Wijtenburg; Min Wang; Stephanie A Korenic; Shuo Chen; Peter B Barker; Laura M Rowland
Journal:  Front Psychiatry       Date:  2021-05-19       Impact factor: 4.157

10.  Thalamus Radiomics-Based Disease Identification and Prediction of Early Treatment Response for Schizophrenia.

Authors:  Long-Biao Cui; Ya-Juan Zhang; Hong-Liang Lu; Lin Liu; Hai-Jun Zhang; Yu-Fei Fu; Xu-Sha Wu; Yong-Qiang Xu; Xiao-Sa Li; Yu-Ting Qiao; Wei Qin; Hong Yin; Feng Cao
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.